The LUNGClear test is a blood test that estimates how likely you are to have lung cancer, by measuring markers in your blood that tend to change when lung cancer is present. It was developed by Mirxes, a Singapore biotechnology company, and is processed in a clinical laboratory licensed by the Ministry of Health (MOH).

Lung cancer is the third most common cancer in Singapore in both men and women, and it rarely causes symptoms in its early stages. About 4 in 5 cases locally are detected at a late stage, when treatment is usually more difficult.

LUNGClear is designed to assess the risk of having lung cancer, so that further tests, such as a low-dose CT scan, can be arranged and any treatment can start earlier if needed. It does not diagnose lung cancer, and it does not replace a low-dose CT scan for people who are advised to have one.

The LUNGClear test measures two kinds of markers in your blood, 12 microRNAs and a protein called carcinoembryonic antigen (CEA), and combines them into a single risk score.

MicroRNAs are tiny molecules found in your cells that help control how they work, and some of them enter your bloodstream. People with lung cancer tend to have a different mix of microRNAs in their blood from people without it.

CEA is a protein that some tumours, including lung tumours, can release into the blood. Its level can also be raised by smoking and may be normal in early lung cancer, which is why it is not used on its own.

The LUNGClear test is intended for healthy adults aged 40 and above who have no symptoms of lung cancer and are not at high risk of it.

The main risk factors are:

Lung cancer can also develop in people with none of these risk factors, and about 1 in 3 people with lung cancer in East Asia have never smoked. Among women with lung cancer in China, more than 8 in 10 have never smoked.

People aged 50 and above who have smoked heavily, now or in the past, are usually advised to have a low-dose CT scan rather than a blood test. This scan uses a small dose of X-rays to take detailed pictures of the lungs.

LUNGClear may suit people who do not qualify for this scan, as it shows whether further tests are needed.

LUNGClear reports your result as a risk score that falls into one of three categories:

A high-risk score is not a diagnosis of lung cancer, while a low-risk score cannot rule it out completely. The score estimates your chance of having lung cancer at the time of testing. It cannot tell you whether you might develop lung cancer later in life.

It also does not take your other risk factors into account, such as smoking or family history, so it is best interpreted alongside them.

A low-dose CT scan of the lungs is usually the next recommended step if further tests are advised.

At ATA Medical, we offer LUNGClear and low-dose CT scans, with consultation and results review. If you would like help to stop smoking, we also offer lifestyle medicine services.

Our prices are as follows:

Test	Price*^
Consultation	From $49.05
LUNGClear Lung Cancer Blood Test	$272.50
Lung Scans and Tests
Chest X-Ray	$49.05
Low-dose CT Scan	$436
Spirometry (Lung Function Test)	$54.50
Other Cancer Blood Tests
GASTROClear Stomach Cancer Blood Test	$272.50
SPOT-MAS Cancer Blood Test	$700
LucenceINSIGHT™ Core (6 Cancers)	$654
LucenceINSIGHT™ Me (9 Cancers)	$1,308
LucenceINSIGHT™ (12 Cancers)	$1,918
LucenceINSIGHT™ Plus (50 Cancers)	$3,798
[Optional] Premium Mobile Blood Drawing at Your Home	Additional $54.50 (per location up to 5 pax)

*Prices are NETT and inclusive of GST.
^Prices last updated on Oct 15, 2026. While every effort is made to keep pricing information up to date, please contact our team to confirm the latest rates.

• Tanjong Pagar Clinic
• Orchard Clinic
• Jurong Clinic
• Novena Clinic